INVESTMENTS – RELATED PARTIES (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
|---|
| SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] |
|
| Schedule of Interest income, related party |
| Schedule of investment |
|
|
|
|
|
|
|
|
|
|
| |
|
Interest |
|
|
|
March 31, |
|
|
December 31, |
|
| |
|
Rate |
|
Due Date |
|
2025 |
|
|
2024 |
|
| Promissory note and accrued interest receivable, Ault & Company, in default |
|
8% |
|
December 31, 2024 |
|
$ |
541,000 |
|
|
$ |
2,468,000 |
|
| Promissory note and accrued interest receivable, GIGA |
|
6% - 12% |
|
In bankruptcy |
|
|
19,440,000 |
|
|
|
18,499,000 |
|
| Other |
|
|
|
|
|
|
335,000 |
|
|
|
335,000 |
|
| Allowance for credit losses |
|
|
|
|
|
|
(500,000 |
) |
|
|
(500,000 |
) |
| Total investment in promissory notes and other, related parties |
|
|
|
|
|
$ |
19,816,000 |
|
|
$ |
20,802,000 |
|
Summary of interest income,
related party, recorded within interest and other income on the condensed consolidated statement of operations:
| Schedule of Interest income, related party | |
| | |
| |
| | |
For the Three Months Ended March 31, | |
| | |
2025 | | |
2024 | |
| Interest income, related party | |
$ | 579,000 | | |
$ | 209,000 | |
|
| Schedule of Interest income, related party |
| Schedule of Interest income, related party | |
| | |
| |
| | |
For the Three Months Ended March 31, | |
| | |
2025 | | |
2024 | |
| Interest income, related party | |
$ | 579,000 | | |
$ | 209,000 | |
|
| Schedule of investment in warrants and common stock |
| Schedule of investment in common stock | |
| |
| | |
Investments in Common Stock, Related Parties at March 31, 2025 | |
| | |
Cost | | |
Gross Unrealized Losses | | |
Fair value | |
| Common shares | |
$ | 24,705,000 | | |
$ | (24,624,000 | ) | |
$ | 81,000 | |
| Alzamend series B convertible preferred stock, warrants | |
| 2,100,000 | | |
| - | | |
| 2,100,000 | |
| | |
$ | 26,805,000 | | |
$ | (24,624,000 | ) | |
$ | 2,181,000 | |
| | |
Investments in Common Stock, Related Parties at December 31, 2024 | |
| | |
Cost | | |
Gross Unrealized Losses | | |
Fair value | |
| Common shares | |
$ | 24,697,000 | | |
$ | (24,607,000 | ) | |
$ | 90,000 | |
| Alzamend series B convertible preferred stock, warrants | |
| 2,100,000 | | |
| - | | |
| 2,100,000 | |
| | |
$ | 26,797,000 | | |
$ | (24,607,000 | ) | |
$ | 2,190,000 | |
The following tables summarize
the changes in the Company’s investments in Alzamend common stock during the three months ended March 31, 2025 and 2024:
| Schedule of investment in warrants and common stock | |
| | |
| |
| | |
For the Three Months Ended March 31, | |
| | |
2025 | | |
2024 | |
| Balance at January 1 | |
$ | 90,000 | | |
$ | 679,000 | |
| Investment in common stock of Alzamend | |
| 8000 | | |
| 5,000 | |
| Unrealized loss in common stock of Alzamend | |
| (17,000 | ) | |
| 84,000 | |
| Balance at March 31 | |
$ | 81,000 | | |
$ | 768,000 | |
|
| Schedule of investment in warrants and common stock |
| Schedule of investment in warrants and common stock | |
| | |
| |
| | |
For the Three Months Ended March 31, | |
| | |
2025 | | |
2024 | |
| Balance at January 1 | |
$ | 90,000 | | |
$ | 679,000 | |
| Investment in common stock of Alzamend | |
| 8000 | | |
| 5,000 | |
| Unrealized loss in common stock of Alzamend | |
| (17,000 | ) | |
| 84,000 | |
| Balance at March 31 | |
$ | 81,000 | | |
$ | 768,000 | |
|
| Schedule of investment in warrants and preferred stock |
| Schedule of investment in warrants and preferred stock | |
| | |
| |
| | |
March 31, | | |
December 31, | |
| | |
2025 | | |
2024 | |
| Investment in Alzamend preferred stock | |
$ | 2,100,000 | | |
$ | 2,100,000 | |
| Total investment in other investments securities, related party | |
$ | 2,100,000 | | |
$ | 2,100,000 | |
|